The aim of the present study was to develop a rapid DNA probe method for the diagnosis of periodontitis that can be used in the dental clinics.
By using the DNA probe, we investigated the correlation between the occurrence of periodontal disease-associated bacteria:
Porphyromonas gingivalis and
Actinobacillus actinomycetemcomitans, and the following clinical parameters: probing depth (PD) and bleeding on probing (BOP).
This method minimizes the use of water bath for ordinary hybridization and washing in order to shorten the total reaction time. Samples were hybridized with boiled DNA probe, and then washed thoroughly with 0.2×SSC/0.1% SDS at 75°C. Detection process could be completed within 2 hours. Detection level was more than 10
4 bacterial cells/sample.
Subgingival plaque samples were taken from 468 sites in 55 patients with periodontitis (age 14-69 years old) before the periodontal initial therapy. After the periodontal therapy of scaling and root planing, 58 sites in 9 patients with periodontitis were bacteriologically and clinically evaluated.
When the DNA probe method was compared with the culture method, the accuracy was 88% for
P. gingivalis, 67% for
A. actinomycetemcomitans.
A statistically significant association was found between the detection of
P. gingivalis and PD, BOP (
x2 test:
p<0.001). A significant association was also shown between the detection of
A. actinomycetemcomitans and PD in patients whose ages were 35 or older (
x2 test:
p<0.001). The relationship between
A. actinomycetemcomitans and BOP was not significant. The detection rate of
A. actinomycetemcomitans was highest in teenagers. At shallow periodontal pocket sites (PD.≤3mm) in teenagers, no
P. gingivalis was found, while 22% of the sites harbored
A. actinomycetemcomitans. After the therapy, the proportions of P. gingivalis decreased significantly only in the clinically resolved sites (
x2 test:
p<0.01). However,
A. actinomycetemcomitans seemed to persist after the therapy.
The rapid DNA probe method appears promising as an efficient tool for rapid diagnosis, selection of treatment modalities, and microbiological evaluation of the treatment outcome.
View full abstract